Promoted Content

Promoted Content

All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

LTS - Lohmann Therapie Systeme

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

GERMANY Germany

Post An Enquiry

CPhI India 2021

Participation Not Confirmed

Update your events

LTS and LIVZON Enter into License and Collaboration Agreement to Develop and Commercialize Asenapine TTS

Contact the Supplier

Lead Product(s): Asenapine Maleate

Therapeutic Area: Psychiatry/Psychology Product Name: Asenapine TTS

Highest Development Status: Preclinical Product Type: Small molecule

Partner/Sponsor/Collaborator: Livzon Pharmaceutical Group Inc.

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement July 06, 2020

Details:

LTS grants to LIVZON and its Affiliates an exclusive royalty-bearing, sublicensable right and license to jointly develop with LTS the Asenapine TTS and commercialize the Asenapine TTS for the treatment of schizophrenia in China (including Hong Kong and Macau).